Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction.

Han Y, Shi D, Li J

Open source

DOI
10.12659/msm.915463
Published
2019 Nov 26
Container
Medical science monitor : international medical journal of experimental and clinical research
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.12659/msm.915463,
  title = {Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction.},
  author = {Han Y and Shi D and Li J},
  year = {2019},
  journal = {Medical science monitor : international medical journal of experimental and clinical research},
  doi = {10.12659/msm.915463},
  url = {https://doi.org/10.12659/msm.915463}
}

RIS

TY  - JOUR
TI  - Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction.
AU  - Han Y
AU  - Shi D
AU  - Li J
PY  - 2019
JO  - Medical science monitor : international medical journal of experimental and clinical research
DO  - 10.12659/msm.915463
UR  - https://doi.org/10.12659/msm.915463
ER  - 

APA

Y, H., D, S., & J, L. (2019). Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction.. Medical science monitor : international medical journal of experimental and clinical research. https://doi.org/10.12659/msm.915463

Source records